FDA approves subcutaneous opdivo qvantig for most solid tumor indications
The U.S. Food and Drug Administration has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) injection for ...
The American Journal of Managed Care2d
FDA Approves First Subcutaneous Nivolumab Injection in Most Solid Tumors
FDA approves the first subcutaneous version of nivolumab, making PD-1 inhibitors available to new groups of patients.
Monthly Prescribing Reference2d
FDA Approves Opdivo Qvantig, a Subcutaneous Formulation of Nivolumab
The approval of Opdivo Qvantig was supported by data from the randomized, open-label phase 3 CheckMate-67T study.
FiercePharma2d
Bristol Myers celebrates 10 years of Opdivo with FDA approval for subcutaneous version
Almost exactly 10 years after the FDA’s initial FDA approval for Bristol Myers Squibb’s Opdivo as the first PD-1 inhibitor in ...
Indiatimes16d
Russia has developed its own cancer vaccine, to be distributed free of charge: News agency
Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...
MedPage Today16d
Pneumococcal Vaccine Responses in People with Inflammatory Arthritis: Worried About Waning?
According to the investigators of a newly published study on the waning of pneumococcal vaccines responses in people with inflammatory arthritis, pneumonia is a major cause of mortality in this ...
Firstpost16d
Russia’s cancer vaccine is ready. Here’s why it matters
Russia has developed a cancer vaccine for patients. Representational Image/Pixabay Russia is all set to roll out a vaccine against cancer in the New Year. It will be available to patients for free ...
USA Today16d
RFK Jr. and vaccines: A history of false and misleading claims | Fact check
A Dec. 10 Instagram post (direct link, archive link) claims Robert F Kennedy Jr.'s comments on vaccines have been limited to advocating for more research. "RFK is saying one thing and one thing ...
FiercePharma18d
FDA rejects J&J's subcutaneous Rybrevant filing and AZ's full approval bid for Andexxa
Johnson & Johnson has received coal in its stocking from the FDA as manufacturing issues have tripped up the company’s attempt to gain approval of its subcutaneous version of lung cancer drug ...
SBS18d
This disease can kill within days. Cases are surging across Australia
Rates of invasive pneumococcal disease are at their highest levels since 2004. While more effective vaccines have been approved for use in Australia, most at-risk people can't get them ...
Sky News Australia18d
Surge in cases of invasive pneumococcal disease spark calls for federal govt to prioritise rollout of newer vaccines for broader protection
“New generation vaccines need to be rolled out through the National Immunisation Program without further delay. We simply can’t risk not having the best available pneumococcal protection ...
Couriermail18d
‘Three-fold challenge’: Immunisation Foundation of Australia warns deadly Pneumococcal disease hits 20-year high
The dangerous pneumococcal disease can be fatal to babies and children. Picture: CDC Pediatrician and infectious disease researcher Professor Peter Richmond said declining rates of vaccination ...